Notícias

ISRG beats second-quarter earnings and revenue estimates, but shares fall after hours as procedure growth slows sequentially despite strong placements.

SYK launches Mako RPS, expanding into handheld robotics for total knee replacement and broadening access to robotic-assisted orthopedic procedures.

Inspire Medical's Inspire V rollout, broader approvals and clinical evidence support growth despite coding and reimbursement pressures.

GE HealthCare's shares rise about 4% after unveiling a $500M, 10-year alliance to deploy 1,300 technologies across Catholic Health.

The companies you own inside this consumer staples fund are collectively signaling stronger profits are on the way.

The company is making its biggest strategic bet in a decade, and it has nothing to do with just hoping for higher metal prices.

On July 14, 2026, Daikyo Seiko, Ltd. entered into two 10‑year Distributorship Agreements with West Pharmaceutical Services, making West the exclusive distributor of Daikyo products outside Japan and appointing Daikyo as a non‑exclusive distributor of West products in Japan, both with early termination options under specific conditions. This long-term cross-distribution structure deepens an existing partnership and could meaningfully reshape West’s global access to high-value injectable...

West Pharmaceutical Services (WST) is back in focus after signing two long term distributorship agreements with Daikyo Seiko, expanding its role as exclusive distributor of Daikyo products outside Japan. See our latest analysis for West Pharmaceutical Services. Alongside the Daikyo agreements, West Pharmaceutical Services has been in focus ahead of its upcoming July 23 earnings release, with the stock showing a 30 day share price return of 8.32% and a 1 year total shareholder return of...

DHR heads into Q2 earnings with bioprocessing and diagnostics strength, but rising costs and debt could pressure profitability.

SNN launches the LYNX COBLATION Laryngeal Wand, combining precise dissection, rapid debulking and hemostasis for airway procedures.

HQY benefits from strong HSA growth, AI-driven automation and solid first-quarter fiscal 2027 results despite data security risks.

GUTS' shares surge after Revita patients retain up to 84% of GLP-1-induced weight loss in a year, compared with 46% for sham patients.

West Pharmaceutical (WST) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

West Pharmaceutical is riding on strong HVP demand, GLP-1 growth and Annex 1 adoption, but can these tailwinds outweigh capacity and concentration risks?

ANGO's Q4 FY26 revenues rise 8% as Med Tech surges, while its adjusted loss beats estimates and FY27 sales guidance tops consensus.

NPCE's RNS adoption, referral growth and AI innovation support expansion, while IGE timing and investments may pressure near-term profits.

VEEV's strong Q1, growing Vault CRM migrations and AI expansion support growth, though life sciences CRM market saturation poses risks.

AVTR's shares jump nearly 7% as NuSil expands its HIV prevention partnership for a three-month dapivirine vaginal ring.

DexCom's G7 15 Day wins Health Canada authorization, offering longer wear, high accuracy and smart features for adults with diabetes.

DGX's Q2 results may reflect growth across physician, hospital and consumer channels as AI tools and advanced diagnostics gain traction.

McKesson, Cardinal, West Pharmaceutical, Align and Henry have been highlighted in this Industry Outlook article.

Over the past six months, West Pharmaceutical Services has been a great trade, beating the S&P 500 by 21.8%. Its stock price has climbed to $353.68, representing a healthy 30.1% increase. This was partly thanks to its solid quarterly results, and the run-up might have investors contemplating their next move.

Here, we highlight five dental supplies stocks, MCK, CAH, WST, ALGN and HSIC, which are well positioned to generate wealth for investors amid improving industry prospect.

ALC is developing adjustable presbyopia-correcting lenses that pair advanced optics with post-surgery light adjustment.

West Pharmaceutical Services (NYSE:WST) has sold the rights and facilities related to its SmartDose 3.5 mL On Body Delivery System to AbbVie. The transaction shifts ownership of this specific large volume wearable injector platform while allowing West Pharmaceutical Services to focus on other drug delivery offerings. The deal reflects a change in how NYSE:WST is positioning its portfolio within the drug delivery and pharmaceutical packaging market. West Pharmaceutical Services operates in...

RMD's MatrixCare sale sharpens its focus on sleep, breathing and connected care while freeing resources for AI-powered digital health.

Natera's Signatera became the first personalized MRD test for solid tumors to earn EU IVDR certification, supporting broader expansion across Europe.

GEHC and Mayo Clinic collaboration aims to advance adaptive cancer theranostics using imaging, biomarkers and clinical data from the MI-BET study.

AVTR's product breadth, digital upgrades and new pharma wins support growth, though VWR Distribution & Services remains a challenge.

MMSI's portfolio, acquisitions, R&D strategy and WRAPSODY upside support growth, though tariffs, China pressure and OEM headwinds persist.